AU3351293A - Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation - Google Patents
Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregationInfo
- Publication number
- AU3351293A AU3351293A AU33512/93A AU3351293A AU3351293A AU 3351293 A AU3351293 A AU 3351293A AU 33512/93 A AU33512/93 A AU 33512/93A AU 3351293 A AU3351293 A AU 3351293A AU 3351293 A AU3351293 A AU 3351293A
- Authority
- AU
- Australia
- Prior art keywords
- fibrinogen
- inhibitors
- acid derivatives
- platelet aggregation
- blood platelet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9201171 | 1992-01-21 | ||
| GB929201171A GB9201171D0 (en) | 1992-01-21 | 1992-01-21 | Chemical compounds |
| GB929206004A GB9206004D0 (en) | 1992-03-19 | 1992-03-19 | Chemical compounds |
| GB9206004 | 1992-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3351293A true AU3351293A (en) | 1993-08-03 |
Family
ID=26300182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU33512/93A Abandoned AU3351293A (en) | 1992-01-21 | 1993-01-15 | Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0623120A1 (en) |
| JP (1) | JPH07503459A (en) |
| CN (1) | CN1077953A (en) |
| AU (1) | AU3351293A (en) |
| IL (1) | IL104446A0 (en) |
| MX (1) | MX9300256A (en) |
| WO (1) | WO1993014077A1 (en) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750754A (en) * | 1993-03-29 | 1998-05-12 | Zeneca Limited | Heterocyclic compounds |
| US5652242A (en) * | 1993-03-29 | 1997-07-29 | Zeneca Limited | Heterocyclic derivatives |
| PT825184E (en) * | 1993-03-29 | 2001-11-30 | Astrazeneca Ab | HETEROCYCLIC DERIVATIVES AS PLATELET INHIBITORS |
| US5753659A (en) * | 1993-03-29 | 1998-05-19 | Zeneca Limited | Heterocyclic compouds |
| ZW4194A1 (en) * | 1993-03-29 | 1994-12-21 | Zeneca Ltd | Heterocyclic compounds |
| GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
| US5463011A (en) * | 1993-06-28 | 1995-10-31 | Zeneca Limited | Acid derivatives |
| GB9313285D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Acid derivatives |
| CN1113875C (en) * | 1994-05-04 | 2003-07-09 | 拜尔公司 | Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| USRE39263E1 (en) * | 1994-05-04 | 2006-09-05 | Bayer Aktiengesellschaft | Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| WO1996024583A1 (en) * | 1995-02-10 | 1996-08-15 | Yamanouchi Pharmaceutical Co., Ltd. | Novel benzamidine derivatives and medicinal composition thereof |
| IL116893A (en) * | 1995-02-10 | 2000-02-29 | Yamanouchi Pharma Co Ltd | Piperazine derivatives and pharmaceutical compositions containing them |
| WO1997002245A1 (en) * | 1995-07-06 | 1997-01-23 | Japan Tobacco Inc. | Benzamidoxime derivatives and medicinal use thereof |
| DE19524765A1 (en) * | 1995-07-07 | 1997-01-09 | Boehringer Mannheim Gmbh | New oxazolidinone derivatives, processes for their preparation and medicaments containing these compounds |
| HUP9901741A3 (en) * | 1996-03-30 | 2000-03-28 | Roche Diagnostics Gmbh | Novel oxazolidine derivatives, process for their production and medicaments containing them |
| NZ334389A (en) * | 1996-08-28 | 2001-05-25 | Ube Industries | Cyclic amine derivatives |
| DE19652919A1 (en) * | 1996-12-19 | 1998-06-25 | Solvay Pharm Gmbh | Piperazinophenyl and piperazinophenyloxycarboxylic acid derivatives and processes and intermediates for their preparation and pharmaceuticals containing these compounds |
| AR013693A1 (en) * | 1997-10-23 | 2001-01-10 | Uriach & Cia Sa J | NEW PIPERIDINES AND PIPERAZINAS AS INHIBITORS OF THE PLAQUETARY AGREGATION |
| ATE238279T1 (en) * | 1998-02-27 | 2003-05-15 | Sankyo Co | CYCLIC AMINO COMPOUNDS |
| WO2004091486A2 (en) | 2003-04-15 | 2004-10-28 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
| MX2007003321A (en) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents. |
| CA2580845A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| WO2006034315A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
| AU2005329423A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| CN101083994A (en) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | Heterocyclic derivatives and their use as therapeutic agents |
| AR051202A1 (en) | 2004-09-20 | 2006-12-27 | Xenon Pharmaceuticals Inc | HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA DESATURASA |
| US7951805B2 (en) | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
| ATE518855T1 (en) | 2005-02-16 | 2011-08-15 | Schering Corp | NEW HETEROCYCLIC SUBSTITUTED PYRIDINE OR PHENYL COMPOUNDS WITH CXCR3 ANTAGONISTIC ACTIVITY |
| CN101163692B (en) * | 2005-02-16 | 2012-01-18 | 先灵公司 | Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| CN101189238A (en) * | 2005-02-16 | 2008-05-28 | 先灵公司 | Piperazine-piperidines with CXCR3 antagonist activity |
| EP1856097B1 (en) * | 2005-02-16 | 2012-07-11 | Schering Corporation | Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| JP2008530213A (en) * | 2005-02-16 | 2008-08-07 | シェーリング コーポレイション | Heteroaryl substituted pyrazinyl-piperazine-piperidine having CXCR3 antagonist activity |
| US7868005B2 (en) * | 2005-02-16 | 2011-01-11 | Schering Corporation | Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| BRPI0611187A2 (en) | 2005-06-03 | 2010-08-24 | Xenon Pharmaceuticals Inc | amino thiazide derivatives as inhibitors of human stearoyl coa desaturase |
| EP1948629A1 (en) | 2005-10-31 | 2008-07-30 | Janssen Pharmaceutica N.V. | Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| WO2010081851A1 (en) | 2009-01-14 | 2010-07-22 | Genoscience Pharma | Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
| US9738604B2 (en) | 2010-09-03 | 2017-08-22 | Duke University | Ethynylbenzene derivatives |
| WO2015024011A2 (en) | 2013-08-16 | 2015-02-19 | Duke University | Antibacterial compounds |
| EP3041354A4 (en) | 2013-08-16 | 2017-06-14 | Duke University | Substituted hydroxamic acid compounds |
| US9908851B2 (en) * | 2013-08-16 | 2018-03-06 | Duke University | 2-piperidinyl substituted N,3-dihydroxybutanamides |
| MA47692A (en) | 2017-02-28 | 2020-01-08 | Morphic Therapeutic Inc | INHIBITORS OF INTEGRIN (ALPHA-V) (BETA-6) |
| BR112019017929A2 (en) | 2017-02-28 | 2020-05-19 | Morphic Therapeutic Inc | integrin (alpha-v) (beta-6) inhibitors |
| CR20210109A (en) | 2018-08-29 | 2021-06-24 | Morphic Therapeutic Inc | INHIBITING av ß6 INTEGRIN |
| CN113075343B (en) * | 2020-01-04 | 2024-02-23 | 东莞市东阳光仿制药研发有限公司 | Hydroxylamine and detection method of hydroxylamine salt |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3207033C2 (en) * | 1981-02-27 | 1984-09-13 | Torii & Co., Ltd., Tokyo | Amidine compounds, processes for their preparation and pharmaceutical compositions containing these compounds |
| US4433152A (en) * | 1981-05-25 | 1984-02-21 | Nippon Chemiphar Co., Ltd. | Amidinopiperidine derivatives |
| PT84171B (en) * | 1986-01-24 | 1989-03-30 | Sanofi Sa | A process for the preparation of derivatives of alpha-arylsulfonylamininoacyl-β-aminophenylalanineamides, as well as their synergistic derivatives and pharmaceutical compositions containing them |
| GB9122016D0 (en) * | 1991-10-16 | 1991-11-27 | Glaxo Group Ltd | Chemical compounds |
-
1993
- 1993-01-15 WO PCT/EP1993/000100 patent/WO1993014077A1/en not_active Application Discontinuation
- 1993-01-15 JP JP5512158A patent/JPH07503459A/en active Pending
- 1993-01-15 EP EP93902223A patent/EP0623120A1/en not_active Withdrawn
- 1993-01-15 AU AU33512/93A patent/AU3351293A/en not_active Abandoned
- 1993-01-20 CN CN93102386A patent/CN1077953A/en active Pending
- 1993-01-20 IL IL104446A patent/IL104446A0/en unknown
- 1993-01-20 MX MX9300256A patent/MX9300256A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07503459A (en) | 1995-04-13 |
| EP0623120A1 (en) | 1994-11-09 |
| WO1993014077A1 (en) | 1993-07-22 |
| CN1077953A (en) | 1993-11-03 |
| MX9300256A (en) | 1993-07-01 |
| IL104446A0 (en) | 1993-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3351293A (en) | Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation | |
| EP0542363A3 (en) | Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation | |
| AU2689292A (en) | Cyclohexaneacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation | |
| AU6375196A (en) | New inhibitors of platelet aggregation | |
| AU4041293A (en) | Phenylderivate as inhibitors of atp citrate lyase | |
| IL86464A (en) | 4-phosphinyl-3- hydroxybutanoic acid derivatives useful as cholesterol biosynthesis inhibitors and pharmaceutical compositions containing the same | |
| AU4936890A (en) | Medicament containing dihydrolipoic acid as active substance | |
| AU635415B2 (en) | Use of n-alkyl-lactams as crystallization inhibitors | |
| AU567236B2 (en) | Pharmaceutical formulation of tissue plasminogen activator | |
| AU3020595A (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments | |
| AU3098189A (en) | Methods and compositions for inhibiting platelet aggregation | |
| AU4533793A (en) | Phenyl amidine urea derivatives as platelet aggregation inhibitors | |
| AU6302596A (en) | Piperidineacetic acid derivatives as inhibitors of fibrinoge n-dependent blood platelet aggregation | |
| AU3040589A (en) | Homoarginine-based peptides as platelet aggregation inhibitors | |
| AU1875988A (en) | 5-aralkyl-2-mercaptoimidazole derivatives as dopamine-beta- hydroxylase inhibitors | |
| AU5906986A (en) | Ascorbic acid for treatment of sino-nasal congestion | |
| AU4801493A (en) | New derivatives of neuraminic acid | |
| AU3506293A (en) | Method of inhibiting the aggregation of blood platelets | |
| ZA888880B (en) | The use of anellated compounds as inhibitors of ertyhrocyte aggregation | |
| AU586306B2 (en) | Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator | |
| AU2296792A (en) | Novel inhibitors of platelet aggregation | |
| AU6180486A (en) | Novel tissue plasminogen activator derivatives | |
| AU4540693A (en) | Phenyl amidine alkanoic acids and lactones useful as platelet aggregation inhibitors | |
| AU6267894A (en) | N-acyl beta amino acid derivatives useful as platelet aggregation inhibitors | |
| AU3494293A (en) | Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors |